UK Industry Sets Out Key Asks On NICE’s Methods Review
As the National Institute for Health and Care Excellence conducts a review of its health technology assessment methods, the Association of the British Pharmaceutical Industry has laid out the key changes it would like to see.
You may also be interested in...
UK health technology appraisal body NICE has released more details about its forthcoming review of the methods it uses for developing guidance on medicines and medical devices.
The COVID-19 pandemic will have a lasting impact on the world, including on Health Technology Assessment (HTA). The debate on how HTA should change as a result of COVID-19 is gaining momentum, but could a wider approach to value and a higher threshold be a false dawn?
The signs suggest that Nicola Magrini, the new director general of the Italian medicines regulator, AIFA, will follow in the footsteps of his predecessor in fighting for transparency in drug pricing.